Drug
Interferon Alfa 2A
Interferon Alfa 2A: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Interferon alfa-2a NCT00000967 | Phase 1 | HIV Infections |
Latest
No recent events.
Follow Interferon Alfa 2A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.